GOLDMAN SACHS GROUP INC - HEPION PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$19,000
-52.5%
14,956
-57.4%
0.00%–
Q4 2021$40,000
+122.2%
35,139
+204.1%
0.00%–
Q3 2021$18,000
-86.7%
11,555
-83.1%
0.00%–
Q2 2021$135,000–68,399–0.00%–
 Download
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders